In Brief: Sodium labeling
This article was originally published in The Tan Sheet
Executive Summary
Sodium labeling: FDA is postponing the effective date of the sodium labeling final rule for OTCs intended for oral ingestion, except for products containing sodium bicarbonate, sodium phosphate or sodium biphosphate, to match that of the calcium, magnesium and potassium labeling final rule. The calcium, magnesium and potassium labeling final rule is expected to be published in the Federal Register "in the near future" and will be effective a year afterward. The delay is in response to requests that the two dates be the same. Both rules call for label content and warnings for products containing specified amounts of the substances. The sodium rule was published a year ago ("The Tan Sheet" April 29, 1996, p. 8)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning